Find Academic Supervisors

Harris H. WangView profile

Associate Professor

• Systems Biology
• Synthetic Biology
• Genome Engineering
• +17 more

Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.

Hauke SmidtView profile

Professor

• Microbiology
• Environmental Microbiology
• Gut Microbiota
• +4 more

Hauke Smidt is a Personal Professor at Wageningen University & Research, affiliated with the Molecular Ecology group within the Faculty of Veterinary Medicine and Animal Sciences. His research focuses on microbial ecology, particularly gut microbiota dynamics, antibiotic resistance, environmental microbiology, and the One Health framework. Smidt has supervised over 50 PhD students and contributed to 519 publications, including studies on microbiome resilience, fermented food impacts, and bioremediation strategies. Education and affiliations include leadership roles in projects addressing antimicrobial resistance, pig health, and drinking water microbiology. His work spans collaborations across Europe and Asia, with notable contributions to understanding microbial community responses to environmental stressors and dietary interventions. Smidt is actively involved in public outreach, as seen in media contributions discussing microbiome research and health benefits. Key projects include aquifer treatment for drinking water, microbiome simulation models, and combating plant pathogens. His awards and recognition are not explicitly listed, but his extensive publication record and project leadership highlight significant academic impact.

• Synthetic Biology
• Systems Biology
• Quantitative Biology
• +5 more

Ting Lu is an Associate Professor at the University of Illinois at Urbana-Champaign in the School of Biomedical and Translational Sciences, focusing on microbial synthetic biology and systems biology. Their research bridges biology, engineering, and physics to reprogram cellular functionalities through gene regulatory networks. Ph.D. in Biophysics, University of California at San Diego (2007) B.S. in Physics, Zhejiang University (2002) Ting Lu's work explores microbial ecosystems, synthetic gene circuits, and their applications in biotechnology and medicine. By combining experimental approaches with mathematical modeling, they investigate bacterial communication networks, metabolic pathways, and spatial dynamics in microbial communities. Selected research trends include microbial consortia engineering for bioremediation and bioproduction, complexity reduction in microbiomes, and predictive modeling of synthetic gene networks. Their publications span high-impact journals such as Nature Communications , Nature Chemical Biology , and eLife . Fellow, American Institute for Medical and Biological Engineering (2022) Future Insight Prize (2021) Donald Biggar Willett Faculty Scholar (UIUC) (2020) NIH Maximizing Investigators' Research Award (2019) NSF CAREER Award (2015) AHA National Scientist Development Grant (2012) Ting Lu's lab has received grants from NIH, NSF, ONR, and industry partners. They offer undergraduate research opportunities in synthetic and systems biology, and teach advanced courses such as BIOE 430 - Intro Synthetic Biology and BIOE 432 - Systems Biology .

• Microbial Genomics
• Gut Microbiome
• Aging and Healthy Aging
• +4 more

Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.

Kelly ArnoldView profile

Associate Professor

• Biomedical Computation and Modeling
• Drug Delivery and Therapeutics
• Systems Immunology
• +5 more

Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.

Lilong ChaiView profile

Associate Professor

• Precision Poultry Farming
• Climate-smart Animal Production
• Animal Welfare
• +3 more

Dr. Lilong Chai serves as an Associate Professor & Engineering Specialist in the Department of Poultry Science at the University of Georgia's College of Agricultural and Environmental Sciences, with affiliate status at the UGA Institute of Integrative Precision Agriculture. His work integrates engineering principles with animal science to advance sustainable poultry production systems through climate-resilient practices and precision farming technologies. His academic foundation includes a Ph.D. in Agricultural and Bio-environmental Engineering from China Agricultural University (2005-2011), B.S. from Anhui Agricultural University (2001-2005), joint Ph.D. studies at Purdue University (2008-2010), and postdoctoral research at Iowa State University (2015-2018) and Agriculture and Agri-Food Canada (2012-2015). Dr. Chai's research program centers on precision poultry farming, climate-smart animal production, and animal welfare enhancement. He pioneers applications of deep learning, computer vision, and environmental engineering to develop real-time monitoring systems for poultry behavior, health indicators, and housing conditions. His work addresses critical industry challenges including floor egg management, footpad dermatitis detection, air quality control, and disease prevention in cage-free systems, emphasizing practical solutions that balance productivity with ethical animal husbandry. Analysis of his 2023-2025 publications reveals dominant themes in AI-driven behavioral monitoring (dustbathing, perching, foraging), thermal imaging for welfare assessment, and sustainable waste management. These studies consistently bridge agricultural engineering, veterinary science, and data analytics to create scalable precision farming tools applicable across commercial poultry operations. His scientific recognition includes 20 major awards such as: Educational Aids Blue Ribbon Award from ASABE (2024) NACAA Communications Award for Precision Poultry Farming Education (2023) Georgia Research Alliance's Georgia Greater Yield selection (2023) ASABE Outstanding Associate Editor Award (2022) Dr. Chai has secured $5 million through 40 competitive grants from USDA-NIFA, NSF, and international agencies as PI/Co-PI. He actively translates research into practice through leadership roles including Coordinator of the Georgia Precision Poultry Farming Conference, Chair of ASABE's Environmental Air Quality Committee, and reviewer for major research foundations. His extension work directly impacts industry stakeholders through annual training programs serving Georgia's poultry sector. His research infrastructure operates within UGA's Poultry Science Department and the Institute of Integrative Precision Agriculture, where he collaborates with interdisciplinary teams to develop next-generation monitoring systems integrating robotics, thermal imaging, and foundation models for real-world poultry applications.

• Pathogen Ecology
• Microbial Evolution
• Antibiotic Resistance
• +4 more

Prof. Dr. Alex Hall is an Associate Professor at the Department of Environmental Systems Science and Head of the Institute of Integrative Biology at ETH Zürich , Switzerland. He holds a PhD from the University of Edinburgh (2008), followed by postdoctoral work at the University of Oxford and ETH Zürich, including prestigious SNSF Ambizione and Marie Curie Intra-European fellowships. Research Focus: The Hall lab investigates Microbial interactions in human microbiomes Antibiotic resistance evolution Horizontal gene transfer dynamics Computational and in vitro modeling of microbial communities Evolutionary medicine applications Scientific Contributions: His recent studies analyze probiotic treatments for Staphylococcus aureus decolonization, strain-specific ecological success in gut microbiomes, and CRISPR-Cas system roles in plasmid conflicts. The lab employs computational frameworks combined with experimental validations. Scientific Awards: SNSF Ambizione fellowship Marie Curie Intra-European fellowship He also serves on the SNSF PRIMA fellowship evaluation panel and the ETH Zürich Coordination Council Medicine .

Lauren AndrewsView profile

Associate Professor

• Synthetic Biology
• Genome Engineering
• Metabolic Engineering
• +5 more

Lauren Andrews serves as Associate Professor and Marvin and Eva Schlanger Faculty Fellow in the Department of Chemical Engineering at the University of Massachusetts Amherst. Her research integrates synthetic biology and genetic engineering to develop programmable cellular systems for biotechnological applications. Education: Postdoctoral Training: Massachusetts Institute of Technology (Biological Engineering and Broad Institute of MIT and Harvard) PhD: University of Colorado Boulder, Chemical Engineering (2012) MS: University of Colorado Boulder, Chemical Engineering (2009) BS: Cornell University, Chemical Engineering (2006) Dr. Andrews' research focuses on establishing genetic design rules for reprogramming cellular regulation and metabolism. Her lab pioneers synthetic gene networks, genetically-encoded biosensors, and high-throughput methodologies for optimizing genetic designs in both model and non-model bacteria. This work enables precise control of cellular sensing, memory, and environmental responses through multiplexed DNA assembly and next-generation sequencing. Analysis of her 15 most recent publications reveals dominant themes in bacterial biosensor development (particularly for bioremediation), quorum sensing engineering, and programmable genetic circuits for probiotic applications. Her research consistently bridges fundamental genetic circuit design with practical implementations in bacterial consortia and non-model organisms. Scientific Awards: Marvin and Eva Schlanger Faculty Fellowship NSF CAREER Award (2020) for "Programmable synthetic microbial consortia for complex multicellular functions" Her grant portfolio demonstrates significant funding for collaborative research in bacterial communication systems and model-guided design of synthetic ecosystems. The Andrews Lab maintains active partnerships with the MIT-Broad Foundry and Cold Spring Harbor Laboratory, where she co-founded the Synthetic Biology Summer Course. Current projects focus on CRISPR-based regulation in non-model bacteria and algorithmic programming of sequential logic in probiotic strains. The Andrews Lab operates within the Life Science Laboratories at UMass Amherst, utilizing advanced facilities for genetic prototyping and high-throughput screening. Her team develops multiplexed tools for exploring genetic design spaces, with particular emphasis on soil bacteria and Gram-positive pathogens for environmental and therapeutic applications.

Sungkwon ParkView profile

Professor

• Livestock production & optimization
• Meat processing: healthy & functionality
• Establishment of environmentally friendly animal production
• +6 more

Sungkwon Park is a Professor in the Department of Food Science and Biotechnology at Sejong University, specializing in advanced food science and biotechnology research with a focus on meat science, cultured meat production, and sustainable food systems. His research integrates molecular biology, food biotechnology, and systems biology to develop innovative food solutions. His educational background includes a Ph.D. from Purdue University (2008), M.S. from Yeungnam University (2001), and B.S. from Yeungnam University (1999). Prior to his current position, he worked as a Postdoctoral Fellow at Virginia Tech (2008-2012) and as a Research Officer at the National Institute of Animal Science, RDA (2012-2015). Professor Park's research interests focus on livestock production optimization, meat processing for health functionality, environmentally friendly animal production systems, and in vitro meat production. His work has led to significant achievements including the identification of calcium and glucose interaction mechanisms in muscle metabolism, development of oleogel-based meat processing techniques, optimization of feed ingredients for sustainable livestock, and establishment of in vitro meat production systems. His recent publications (2023-2025) demonstrate a strong focus on cultured meat technology, meat science, and sustainable food production. The research spans cellular mechanisms for cultured meat production, safety and regulatory aspects of alternative proteins, comparative analysis of muscle satellite cells, and optimization of meat processing techniques. His work shows a clear trend toward developing practical applications for next-generation meat products with emphasis on health functionality and environmental sustainability. Professor Park actively serves as a reviewer for Frontiers in Veterinary Science and is an Editorial Board Member of the Korean Society of Animal Science. His laboratory, the M&M'a lab (Functional Food Lab), conducts research on high-value-added, health-functional BioFood and future foods using bio-convergence technologies.

• Nutritional Systems Biology
• Food Science
• Bioactive Compounds
• +3 more

Prof. Veronika Somoza is a leading academic in Nutritional Systems Biology, currently affiliated with the University of Vienna and Technical University of Munich (TUM). She holds a professorship in Molecular Food Science and has led key research groups such as the Institute of Physiological Chemistry and the Christian Doppler Laboratory for Bioactive Aromatics. Her career includes roles at institutions like the German Research Institute for Food Chemistry (Garching) and the University of Wisconsin-Madison. Education: Diplom (Justus Liebig University Giessen, 1991), PhD (University of Vienna, 1995), Habilitation (Kiel University, 2002) Research Focus: Bioactive food compounds, flavor chemistry, taste receptor signaling, and gastrointestinal physiology Her work bridges food science and human health, particularly in understanding how food ingredients influence digestion, inflammation, and disease. Notable contributions include discoveries on bitter peptide effects on gastric acid secretion and flavor perception modulation. Awards: FEMA Excellence in Flavor Science (2016), ACS AGFD Fellow (2020), Hans Adolf Krebs Prize (2004) Prof. Somoza has pioneered methodologies in atomic force microscopy for foodborne virus detection and developed bitterness-masking compounds for pharmaceuticals. Her interdisciplinary approach integrates nanobiophysics with nutrition to advance functional food design and clinical applications.

Michael BaymView profile

Associate Professor

• Microbial Evolutionary Genomics
• Antibiotic Resistance
• Computational Biology
• +7 more

Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .

• Respiratory Drug Delivery
• Pulmonary Drug Delivery
• Inhalation Aerosols
• +5 more

Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.

Juliane NguyenView profile

Professor

• Molecular Engineering
• Protein-based Therapeutics
• Live Biotherapeutics
• +7 more

Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.

Pedro FardimView profile

Professor

• Chemical Engineering for Human Health
• Biochemical Process Engineering
• Biomass Engineering
• +12 more

Pedro Fardim is a Professor at the KU Leuven , affiliated with the Faculty of Engineering Sciences, Department of Chemical Engineering , and leads the Chemical and Biochemical Reactor Technology and Safety (CREaS) division. He also serves as President of EPNOE (European Polysaccharide Network of Excellence) and is a member of multiple institutes including KU Leuven Brain Institute (LBI) , Institute for Single Cell Omics (LISCO) , and Institute for Micro- and Nano-scale Integration (LIMNI) . PhD in Chemistry, State University of Campinas (UNICAMP), Brazil Habilitation in Chemical Engineering, Åbo Akademi University, Finland Pedro’s research focuses on topochemical engineering —mimicking natural bioassembly processes in trees and microorganisms to create sustainable materials and biofabrication technologies . His work spans drug delivery , regenerative medicine , biopolymer engineering , and green chemistry , with applications in pharmaceuticals , cosmetics , and energy . Recent projects include hydrogels for wearable sensors , biohybrid materials for bone tissue engineering , and lignin valorization using hydrotropic solvents. His scientific awards include Fellowships from the Royal Society of Chemistry and the International Academy of Wood Science , along with membership in the American Chemical Society . He teaches Chemical Engineering for Human Health , Biochemical Process Engineering , and Biopolymer-based Sustainable Technologies .

• Microbiome
• Host-Microbe Interactions
• Environmental Microbiology
• +5 more

Prof. Dr. Michael Schloter serves as Director of the Research Unit for Comparative Microbiome Analysis at Helmholtz Munich since 2011 and holds a Professorship in Microbiology at the Technical University of Munich since 2010. He concurrently acts as Principal Investigator at both the German Center for Lung Diseases (DZL) and the Central for Food and Nutrition (ZIEL) at TU Munich, driving interdisciplinary research at the intersection of environmental and human health through the "Planetary Health" framework. His educational foundation was built through diploma studies at Ludwig Maximilian University Munich and doctoral research at the University of Bayreuth, followed by formative work in Brazil and the United States where he pioneered bioinocula development for stress-resilient agriculture. At Helmholtz Munich (formerly GSF), he evolved from group leader in soil microbial ecology (2001) to Research Unit Director, expanding his focus from agricultural systems to human microbiome-health connections. Dr. Schloter's research program centers on microbiome-host crosstalk across ecological scales, investigating how environmental microbiota interact with human and plant microbiomes to influence health outcomes. His work integrates ecological theory with microbiome analysis to decode host-microbe co-evolution patterns, with applications spanning sustainable agriculture, allergy prevention, and infection control. Key thematic pillars include holobiont theory, probiotic development, and microbiome-mediated disease prevention through environmental quality improvement. Analysis of his 2025 publications reveals a strategic research portfolio bridging fundamental and applied microbiome science. Agricultural studies dominate (maize, potato, apple systems), examining microbial inoculants and soil management, while human health investigations explore preterm birth complications and Antarctic mammal microbiomes. Computational approaches for antimicrobial resistance assessment and ecosystem-scale projects like JenaTron demonstrate methodological breadth, all converging on translating microbiome functionality into real-world sustainability solutions. Major recognitions include: Election to the Bavarian Academy of Science (2021) Consistent placement among the top 1% of highly cited global researchers (2019-2021) Heinrich Baur Research Award (2011) for agricultural microbiology contributions As Research Unit Director, Schloter leads large-scale collaborative initiatives including the DZL and ZIEL consortia, securing major funding for microbiome standardization projects and international research networks. His leadership extends to developing analytical frameworks for cross-ecosystem microbiome comparisons and establishing protocols for translating microbial ecology principles into clinical and agricultural applications. The Comparative Microbiome Analysis unit operates as a nexus for multi-host microbiome research, employing comparative genomics, field-scale agricultural trials, and clinical cohort studies to investigate microbiome dynamics across environmental, plant, and human systems. Current infrastructure includes advanced sequencing facilities and experimental platforms for plant-microbe and host-microbe interaction studies under controlled and natural conditions.